Diabetic Retinopathy

Diabetic retinopathy is the most common microvascular complication of diabetes. It remains a major cause of new-onset visual loss in the United States and other industrialized nations. In Diabetic Retinopathy, Elia Duh and a panel of internationally recognized experts comprehensively assess the curr...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Duh, Elia. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2008.
Edition:1st ed. 2008.
Series:Contemporary Diabetes,
Subjects:
Online Access:https://doi.org/10.1007/978-1-59745-563-3
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Clinical Aspects of Diabetic Retinopathy
  • Nonproliferative Diabetic Retinopathy
  • Proliferative Diabetic Retinopathy
  • The Epidemiology of Diabetic Retinopathy
  • Diagnostic Modalities in Diabetic Retinopathy
  • Pathophysiology / Basic Research
  • In Vivo Models of Diabetic Retinopathy
  • The Polyol Pathway and Diabetic Retinopathy
  • The Role of Advanced Glycation in Diabetic Retinopathy
  • The Role of Protein Kinase C in Diabetic Retinopathy
  • Oxidative Stress in Diabetic Retinopathy
  • Pericyte Loss in the Diabetic Retina
  • Capillary Dropout in Diabetic Retinopathy
  • Neuroglial Dysfunction in Diabetic Retinopathy
  • The Role of Inflammation in the Pathophysiology of Diabetic Retinopathy
  • Vascular Permeability in Diabetic Retinopathy
  • Retinal Neovascularization and the Role of VEGF
  • Beyond VEGF – Other Factors Important in Retinal Neovascularization: Potential Targets in Proliferative Diabetic Retinopathy
  • Emerging Treatments and Concepts in Diabetic Retinopathy
  • Anti-VEGF Therapy as an Emerging Treatment for Diabetic Retinopathy
  • Clinical Trials in Protein Kinase C-? Inhibition in Diabetic Retinopathy
  • The Role of Intravitreal Steroids in the Management of Diabetic Retinopathy
  • Antagonism of the Growth Hormone Axis as a Therapeutic Strategy for Diabetic Retinopathy
  • Diabetic Retinopathy and Systemic Complications.